
Movano Health Unveils Upcoming Launch of Evie Ring Focused on Women’s Health
10-30-23 (by: Scott Gleason) Movano Health has officially announced its Evie Ring, a smart ring designed to cater to women’s health needs, is set to launch on November 20 and will be available for direct orders through the company’s commercial website.
Designed to provide women with health insights, the Evie Ring the ring has a comprehensive suite of health and wellness metrics specifically targeted to womens’ health. The ring can monitor vital health indicators such as heart rate, blood oxygen saturation, sleep stages, activity levels, and menstrual cycles. It comes with a personalized app experience tailored to each woman’s unique health objectives. Instead of merely assigning scores to physical activity and fitness performance, the Evie Ring focuses on providing healthy ranges and offering actionable insights based on an individual’s data. It also is adaptable to changing women’s bodies and can accommodate swelling.
In August, Movano Health announced it had submitted a 510(k) premarket notification to the FDA for the Evie Ring. This submission is currently undergoing evaluation by the FDA. A pivotal trial in Q4 2022 with the University of California, San Francisco (UCSF) demonstrated the Evie Ring’s clinical performance, specifically its accuracy in measuring blood oxygen saturation (SpO2). In the trial, the ring achieved a mere 2% margin of error, surpassing the FDA’s guidance of 3.5% for SpO2.
The device will compete against other smart wearable technologies such as ŌURA’s similar smart ring.